SCHEMBL20364015

SCHEMBL20364015

Cc1cc(-c2ccc(-c3ccncc3)cc2)cc(C)[n+]1C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.50
KDM4E B2RXH2 1/20 0.50
HTT P42858 1/20 0.50
PABPC1 P11940 1/20 0.48
APOBEC3A P31941 1/20 0.48
EIF4H Q15056 1/20 0.48
APOBEC3G Q9HC16 1/20 0.48
MAPT P10636 2/20 0.48
LMNA P02545 1/20 0.48
KIF11 P52732 3/20 0.43
QDPR P09417 1/20 0.42
NOTUM Q6P988 1/20 0.41
CYP17A1 P05093 3/20 0.38
CYP11B1 P15538 3/20 0.38
CYP21A2 P08686 2/20 0.38
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
AAK1 Q2M2I8 1/20 0.37
MAPK14 Q16539 1/20 0.37
PDE3B Q13370 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20364013 0.78 MAPT (0.48) SMN1; SMN2KDM4EHTTPABPC1APOBEC3A
SCHEMBL5159873 0.78 KDM4E (0.50) SMN1; SMN2KDM4EHTTCYP3A4
SCHEMBL18748287 0.75 MAPT (0.73) SMN1; SMN2PABPC1APOBEC3AEIF4HAPOBEC3G
SCHEMBL13907332 0.75 MAPT (0.73) SMN1; SMN2PABPC1APOBEC3AEIF4HAPOBEC3G
SCHEMBL13907285 0.75 MAPT (0.73) SMN1; SMN2PABPC1APOBEC3AEIF4HAPOBEC3G
SCHEMBL19270240 0.75 MAPT (0.73) SMN1; SMN2PABPC1APOBEC3AEIF4HAPOBEC3G
SCHEMBL8105523 0.75 PABPC1 (0.55) SMN1; SMN2KDM4EHTTPABPC1APOBEC3A
SCHEMBL27430947 0.75 MAPT (0.55) SMN1; SMN2KDM4EPABPC1APOBEC3AEIF4H
Hydrochloric Acid SCHEMBL3825788 0.74 PABPC1 (0.53) SMN1; SMN2KDM4EHTTPABPC1APOBEC3A
SCHEMBL13915993 0.72 MAPT (0.79) SMN1; SMN2KDM4EPABPC1APOBEC3AEIF4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180194995-A1 ELECTROCHROMIC COMPOUNDS AND OPTICAL ARTICLES CONTAINING THEM ESSILOR INTERNATIONAL (FR) 2018-07-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180194995-A1 ELECTROCHROMIC COMPOUNDS AND OPTICAL ARTICLES CONTAINING THEM EYA2, EYA3, ALDH1A2 SMN1; SMN2 4631/4885KDM4E 1575/4885HTT 1109/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.